Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2015) | Total Docs. (3years) | Total Refs. (2015) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2015) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 71 | PharmacoEconomics - Italian Research Articles | journal | 0.101 Q4 | 9 | 3 | 33 | 39 | 0 | 26 | 0.00 | 13.00 |  |
| 70 | Clinical Pharmacist | journal | 0.111 Q4 | 11 | 69 | 153 | 568 | 4 | 99 | 0.01 | 8.23 | |
| 69 | Drugs and Therapy Perspectives | journal | 0.112 Q4 | 13 | 72 | 216 | 1854 | 12 | 216 | 0.06 | 25.75 | |
| 68 | MeReC Bulletin | journal | 0.123 Q4 | 7 | 0 | 5 | 0 | 0 | 1 | 0.00 | 0.00 | |
| 67 | Prescriber | journal | 0.123 Q4 | 4 | 7 | 1 | 107 | 0 | 1 | 0.00 | 15.29 | |
| 66 | Clinical Practice | journal | 0.133 Q4 | 10 | 5 | 230 | 87 | 60 | 193 | 0.27 | 17.40 | |
| 65 | Drug and Therapeutics Bulletin | journal | 0.138 Q3 | 17 | 138 | 425 | 984 | 43 | 123 | 0.13 | 7.13 | |
| 64 | Klinik Psikofarmakoloji Bulteni | journal | 0.178 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 63 | Expert Opinion on Orphan Drugs | journal | 0.213 Q3 | 27 | 124 | 230 | 10230 | 120 | 227 | 0.52 | 82.50 | |
| 62 | Pharmaceutical Medicine | journal | 0.252 Q3 | 25 | 24 | 63 | 793 | 41 | 52 | 0.49 | 33.04 | |
| 61 | Molecular Therapy - Oncolytics | journal | 0.272 Q3 | 42 | 22 | 6 | 1480 | 4 | 5 | 0.67 | 67.27 | |
| 60 | Journal of Oncology Pharmacy Practice | journal | 0.424 Q3 | 44 | 50 | 227 | 1205 | 260 | 214 | 1.01 | 24.10 | |
| 59 | Journal of Chemotherapy | journal | 0.512 Q2 | 56 | 70 | 195 | 1923 | 277 | 175 | 1.28 | 27.47 | |
| 58 | BMC Clinical Pharmacology | journal | 0.557 Q2 | 43 | 0 | 14 | 0 | 44 | 14 | 0.00 | 0.00 | |
| 57 | Therapeutic Advances in Cardiovascular Disease | journal | 0.595 Q2 | 41 | 47 | 74 | 1691 | 124 | 62 | 1.61 | 35.98 | |
| 56 | Fundamental and Clinical Pharmacology | journal | 0.637 Q2 | 85 | 64 | 232 | 2798 | 485 | 232 | 2.39 | 43.72 | |
| 55 | European Journal of Contraception and Reproductive Health Care | journal | 0.653 Q2 | 53 | 52 | 179 | 1449 | 232 | 169 | 1.30 | 27.87 | |
| 54 | Clinical Drug Investigation | journal | 0.664 Q2 | 67 | 97 | 346 | 2682 | 690 | 328 | 1.98 | 27.65 | |
| 53 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.708 Q2 | 81 | 124 | 339 | 3722 | 717 | 334 | 2.22 | 30.02 | |
| 52 | Biopharmaceutics and Drug Disposition | journal | 0.733 Q2 | 65 | 52 | 149 | 1987 | 408 | 144 | 2.66 | 38.21 | |
| 51 | International Journal of STD and AIDS | journal | 0.753 Q2 | 78 | 174 | 630 | 4767 | 752 | 592 | 1.33 | 27.40 | |
| 50 | Therapeutic Advances in Respiratory Disease | journal | 0.763 Q2 | 50 | 32 | 85 | 1302 | 225 | 75 | 2.44 | 40.69 | |
| 49 | Expert Review of Anticancer Therapy | journal | 0.795 Q2 | 85 | 127 | 473 | 8904 | 1016 | 449 | 2.07 | 70.11 | |
| 48 | BMC Pharmacology | journal | 0.805 Q2 | 48 | 0 | 8 | 0 | 32 | 8 | 0.00 | 0.00 | |
| 47 | Expert Review of Clinical Pharmacology | journal | 0.817 Q2 | 60 | 58 | 249 | 4113 | 574 | 215 | 2.41 | 70.91 | |
| 46 | Expert Review of Pharmacoeconomics and Outcomes Research | journal | 0.818 Q2 | 61 | 103 | 253 | 4429 | 519 | 243 | 1.81 | 43.00 | |
| 45 | AIDS Research and Therapy | journal | 0.851 Q2 | 49 | 44 | 109 | 1512 | 210 | 108 | 1.76 | 34.36 | |
| 44 | BMC pharmacology & toxicology | journal | 0.853 Q2 | 43 | 41 | 160 | 1456 | 393 | 154 | 2.57 | 35.51 | |
| 43 | Paediatric Drugs | journal | 0.855 Q2 | 70 | 50 | 142 | 3028 | 340 | 136 | 2.56 | 60.56 | |
| 42 | BioDrugs | journal | 0.894 Q2 | 79 | 35 | 146 | 2111 | 483 | 141 | 3.39 | 60.31 | |
| 41 | Expert Opinion on Pharmacotherapy | journal | 0.907 Q2 | 93 | 251 | 734 | 17110 | 2183 | 705 | 3.15 | 68.17 | |
| 40 | American Journal of Cardiovascular Drugs | journal | 0.920 Q2 | 60 | 44 | 128 | 2273 | 322 | 121 | 2.49 | 51.66 | |
| 39 | Human Psychopharmacology | journal | 0.974 Q2 | 86 | 52 | 232 | 2845 | 657 | 227 | 3.03 | 54.71 | |
| 38 | HIV Clinical Trials | journal | 1.027 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 37 | Expert Review of Neurotherapeutics | journal | 1.037 Q2 | 98 | 110 | 448 | 8907 | 1298 | 413 | 2.60 | 80.97 | |
| 36 | Expert Opinion on Emerging Drugs | journal | 1.051 Q2 | 54 | 50 | 125 | 4861 | 374 | 122 | 2.58 | 97.22 | |
| 35 | Expert Opinion on Drug Safety | journal | 1.058 Q1 | 90 | 164 | 341 | 12223 | 1142 | 332 | 3.37 | 74.53 | |
| 34 | Antimicrobial Resistance and Infection Control | journal | 1.093 Q1 | 66 | 56 | 101 | 1772 | 295 | 89 | 2.92 | 31.64 | |
| 33 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 1.110 Q1 | 57 | 60 | 177 | 2823 | 515 | 172 | 3.10 | 47.05 | |
| 32 | Acta Pharmacologica Sinica | journal | 1.136 Q1 | 117 | 152 | 548 | 7530 | 1739 | 538 | 3.12 | 49.54 | |
| 31 | Pharmaceutical Statistics | journal | 1.180 Q1 | 46 | 57 | 160 | 1388 | 177 | 149 | 1.20 | 24.35 | |
| 30 | Trials | journal | 1.235 Q1 | 98 | 594 | 1197 | 24419 | 2965 | 1176 | 2.23 | 41.11 | |
| 29 | Cardiovascular Therapeutics | journal | 1.259 Q1 | 54 | 50 | 192 | 1995 | 578 | 181 | 2.50 | 39.90 | |
| 28 | Journal of Biomedical Science | journal | 1.316 Q1 | 110 | 100 | 300 | 5106 | 1068 | 300 | 3.36 | 51.06 | |
| 27 | Therapeutic Advances in Vaccines | journal | 1.335 Q1 | 5 | 0 | 6 | 0 | 36 | 6 | 6.00 | 0.00 | |
| 26 | Expert Opinion on Investigational Drugs | journal | 1.341 Q1 | 117 | 132 | 440 | 11218 | 1719 | 434 | 3.84 | 84.98 | |
| 25 | Drug Safety | journal | 1.365 Q1 | 140 | 104 | 320 | 5108 | 1101 | 281 | 3.60 | 49.12 | |
| 24 | Antiviral Therapy | journal | 1.388 Q1 | 93 | 107 | 425 | 3198 | 1177 | 409 | 2.76 | 29.89 | |
| 23 | Drugs and Aging | journal | 1.389 Q1 | 109 | 98 | 280 | 6080 | 1032 | 265 | 3.45 | 62.04 | |
| 22 | Therapeutic Advances in Drug Safety | journal | 1.451 Q1 | 46 | 23 | 68 | 866 | 288 | 62 | 4.59 | 37.65 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data